We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

February 25, 2014

In re Solodyn (Minocycline Hydrochloride) Antitrust Litigation

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. July 19, 2018

    Class Attorneys Secure $40M From Solodyn Pay-For-Delay

    A Massachusetts federal judge greenlighted more than $40 million in attorneys’ fees that consumers, pharmacies and health plans racked up during four years of multidistrict litigation and a three-week trial alleging several U.S. drugmakers colluded to delay a generic alternative to brand-name acne medication Solodyn.

18 other articles on this case. View all »

Parties

To view the parties, register now.